Fundraising Fox

Marina Biotech

Bothell, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

JM
J. Michael FrenchExecutive
RT
Richard T. HoExecutive

Board

RJ
R. John FletcherBoard director
DA
Donald A. WilliamsBoard director
SL
Stefan LorenBoard director
PC
Philip C. RankerBoard director
JW
Joseph W. RamelliBoard director
JM
James M. KarisBoard director
PD
Peter D. ParkerBoard director
MT
Michael TaylorBoard director
GS
Gregory SesslerBoard director

Investors · 1

Pappas CapitalDurham

Reported raises · per SEC filings

Form D private placements

$25.2M disclosed across 10 rounds · 2011–2019

▶$499.9KraisedFeb 2020 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Uli HacksellDirector
  • Tim BorisDirector
  • Rhonda StanleyExecutive Officer
  • Nancy PhelanExecutive Officer, Director
Offering amount
$499.9K
Amount sold
$499.9K
Minimum investment
$499.9K
Sales commissions
$50K
Placement agents
Maxim Group LLC
First sale
Jun 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.2MraisedJul 2019 · 45 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Uli HacksellDirector
  • Tim BorisDirector
  • Nancy PhelanExecutive Officer, Director
  • Erik EmersonDirector
  • Issac BlechDirector
  • Donald A. WilliamsDirector
Offering amount
$7M
Amount sold
$3.2M
Minimum investment
$10K
Sales commissions
$323.9K
Placement agents
Maxim Group LLC
First sale
Jun 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedJul 2018 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert C. MoscatoExecutive Officer, Director
  • Amit ShahExecutive Officer
  • Tim BorisDirector
  • Issac BlechDirector
  • Donald A. WilliamsDirector
  • Erik EmersonExecutive Officer, Director
  • Vuong TrieuDirector
  • Uli HacksellDirector
Offering amount
$11M
Amount sold
$1.5M
Minimum investment
$30K
Sales commissions
$154K
Placement agents
Maxim Group LLC
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.7MraisedApr 2018 · 97 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Vuong TrieuExecutive Officer, Director
  • Issac BlechDirector
  • Philippe CalaisDirector
  • Amit ShahExecutive Officer
  • Philip C. RankerDirector
  • Donald A. WilliamsDirector
  • Joseph W. RamelliExecutive Officer
Offering amount
$15M
Amount sold
$11.7M
Minimum investment
$20K
Sales commissions
$1.2M
Placement agents
Maxim Group LLC
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedNov 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip C. RankerDirector
  • Donald A. WilliamsDirector
  • Philippe CalaisDirector
  • Vuong TrieuExecutive Officer, Director
  • Joseph W. RamelliExecutive Officer
  • Isaac BlechDirector
Offering amount
$500K
Amount sold
$500K
Minimum investment
$500K
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$224.4KraisedJun 2017 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Vuong TrieuDirector
  • Donald A. WilliamsDirector
  • Philippe CalaisDirector
  • Philip C. RankerDirector
  • Joseph W. RamelliExecutive Officer
  • Stefan LorenDirector
Offering amount
$500K
Amount sold
$224.4K
Minimum investment
$1.1K
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedJun 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph W. RamelliExecutive Officer, Director
  • Donald A. WilliamsDirector
  • Philip C. RankerDirector
  • Stefan LorenDirector
Offering amount
$300K
Amount sold
$300K
Minimum investment
$50K
First sale
Jun 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedAug 2015 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald A. WilliamsDirector
  • Stefan LorenDirector
  • J. Michael FrenchExecutive Officer, Director
  • Philip C. RankerDirector
  • Joseph W. RamelliDirector
Offering amount
$1.1M
Amount sold
$1.1M
Minimum investment
$100K
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Marina Biotech Inc. Raises $1.5 Million - Los Angeles Business Journallabusinessjournal.com · Jul 2018Marina Biotech: A Forgotten And Grossly Undervalued Game Changer | Nasdaqnasdaq.com · Nov 2014Marina Biotech Ceases Most Day-to-Day Operations | Fierce Biotechfiercebiotech.com · Jun 2012Marina Biotech hits a funding wall, shuts down RNAi ops | Fierce Biotechfiercebiotech.com · Jun 2012Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Adds $6.9M - BioSpacebiospace.com · May 2011Marina Biotech ($MRNA) raises $3.3 million | Fierce Pharmafiercepharma.com · Nov 2010

Frequently asked questions

Who are Marina Biotech's investors?
Marina Biotech's investors include Pappas Capital.
How much funding has Marina Biotech raised?
Marina Biotech has disclosed $25.2M raised across 10 rounds.
Where is Marina Biotech headquartered?
Marina Biotech is headquartered in Bothell, US.